Sanuwave is pleased to announce preliminary revenues of $13.3 million to $13.4 million for the fourth quarter ended December 31, 2025. This represents the highest quarterly revenues in Company history. Q4 2025 revenue increased between 29% and 30% compared to Q4 2024. Full Year 2025 revenue increased to $44.3-$44.4 million up 36% vs Full Year 2024. 2025 annual revenues were an all-time record for the Company. EDEN PRAIRIE, Minn., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "San ...

Valued at a market cap of $14.4 billion, Solventum Corporation (SOLV) is a Minnesota-based healthcare company, focused on delivering medical and health technology solutions. The company operates in medical-surgical products, dental solutions, health information systems, and purification and filtration technologies, serving hospitals, dental practices, and healthcare providers globally. Companies worth $10 billion or more are typically classified as “large-cap stocks,” and SOLV fits the label perfectly, w ...